Virtual Crossover Study for Clinical Diagnostic Analyzers

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current clinical diagnostic processes face inefficiencies and inaccuracies in conducting crossover studies for quality control materials, requiring extensive data collection and manual processing, which is time-consuming, costly, and often results in high error margins, especially when switching to new lots of quality control materials.

Innovation Solution

A system and method for conducting virtual crossover studies using clinical diagnostic analyzers that leverage data from peer groups already using the new lot of quality control material, employing a Bayesian approach to estimate mean and standard deviation, allowing laboratories to begin testing sooner and minimizing the impact on operations by using predicted values initially, which are updated with actual data as it becomes available.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional crossover studies are conducted by collecting data over twenty days with at least twenty measurements per control level, then measurement precision and reliability are improved, but loss of time and productivity deteriorate significantly

Engineering Contradiction:
Improveaccuracy of mean and SD estimationVSAvoidcrossover study duration
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The system performs preliminary actions by collecting and analyzing data from peer group laboratories before the individual laboratory completes its full crossover study. The virtual crossover study initiates mean and SD estimation using peer data immediately, rather than waiting for the traditional 20-day period, thereby reducing time loss while maintaining precision through continuous data integration.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent merges data from multiple sources - peer group laboratories and the individual laboratory's own measurements - into a unified statistical model. This combination allows the system to achieve accurate mean and SD estimation faster by pooling data across the peer network, effectively reducing the time required while maintaining or improving measurement precision.

Inventive Principle:
Principle #5Merging (Combining)

2Device complexity

If manual data processing using spreadsheets is used for crossover studies, then device complexity is reduced, but loss of time and productivity worsen due to manual input and calculation requirements

Engineering Contradiction:
Improvesystem simplicityVSAvoiddata processing efficiency
Core Design Contradiction:
Device complexityVSProductivity

Solution Approach 1:

The system performs self-service by automatically collecting data from peer group laboratories, calculating mean and SD values, and updating estimates without requiring manual data entry or spreadsheet manipulation. The automated statistical calculations and data integration processes eliminate manual labor while maintaining system accessibility and ease of use.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent replaces the mechanical system of manual spreadsheet data entry and calculation with an automated electronic system. The clinical diagnostic analyzer and server automatically perform data collection, statistical computation, and result generation, substituting manual mechanical operations with automated electronic processing, thereby dramatically improving productivity without excessive complexity.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Reliability

If crossover studies are conducted for every new lot of quality control material, then reliability of quality control is improved, but loss of time and productivity worsen due to repeated extensive studies

Engineering Contradiction:
Improvequality control accuracyVSAvoidtesting throughput
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The virtual crossover study performs preliminary validation of new quality control material lots by utilizing data from peer group laboratories that have already completed their crossover studies. This preliminary action provides immediate mean and SD estimates, allowing the individual laboratory to begin testing with new lots without waiting for the full traditional study period, thereby improving productivity while maintaining reliability through ongoing validation.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system applies universality by using a single peer group data network to serve multiple laboratories simultaneously. The same peer group data infrastructure supports crossover studies for numerous laboratories across different institutions, allowing each laboratory to benefit from the collective data without duplicating the entire study process, thereby improving both reliability and productivity across the network.

Inventive Principle:
Principle #6Universality (Multi-functionality)

4Measurement precision

If extensive data collection over multiple days is performed, then measurement precision improves, but expense and labor intensity worsen

Engineering Contradiction:
Improvestatistical accuracyVSAvoidconsumption of quality control material
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The system merges the data collection efforts of multiple peer group laboratories into a unified statistical analysis. By pooling data across the peer network, the system achieves high statistical accuracy for mean and SD estimation without requiring each individual laboratory to consume large quantities of quality control material over extended periods, thereby reducing material consumption while maintaining measurement precision.

Inventive Principle:
Principle #5Merging (Combining)

Data Source

PatentUS12148511B2System and method for conducting virtual crossover studies in clinical diagnostic processes
Publication Date: 2024.11.19 BIO RAD LABORATORIES INC
  • US12148511B2 patent drawing
  • US12148511B2 patent drawing
  • US12148511B2 patent drawing

AI summary

A clinical diagnostic analyzer for performing a virtual crossover study on quality control (QC) material includes a processor, memory, measurement hardware, and an input panel/display. The analyzer acquires data from a peer group relating to a new lot of quality control material to calculate a predicted mean and standard deviation based on that peer group data and adjusted for bias in the laboratory process. As new analyses are run on the new lot of QC material, the predicted mean and standard deviation are updated to incorporate the actual data on a weighted basis.